Lovisa Afzelius, Metaphore Biotechnologies CEO

Metaphore Biotech­nolo­gies seeks to mim­ic na­ture with $50M for au­toim­mune, im­munol­o­gy drugs out of Flag­ship

Flag­ship Pi­o­neer­ing has churned out an­oth­er biotech start­up that taps in­to na­ture’s seem­ing­ly end­less sup­ply of in­sights and, like many new life sci­ences com­pa­nies, is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.